Naringenin inhibits human osteoclastogenesis and osteoclastic bone resorption

V D La1, S Tanabe, D Grenier

  • 1Groupe de Recherche en Ecologie Buccale, Faculté de Médecine Dentaire, Université Laval, 2420 Rue de la Terrasse, Quebec City, Quebec, Canada.

Abstract

Insights

Naringenin significantly inhibits human osteoclastogenesis and bone resorption by decreasing key inflammatory factors. This flavonoid shows potential for treating bone diseases like periodontitis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Naringenin is a flavonoid with diverse pharmacological effects.
  • Osteoclastogenesis and bone resorption are critical processes in bone metabolism.
  • Dysregulation of these processes contributes to various bone diseases.

Purpose of the Study:

  • To investigate the impact of naringenin on human osteoclastogenesis.
  • To evaluate naringenin's effect on osteoclastic bone resorption.

Main Methods:

  • Human osteoclast precursor cells were cultured and stimulated with RANKL and M-CSF.
  • Osteoclastogenesis was quantified by TRAP staining.
  • Bone resorption was assessed using an OsteoAssay human bone plate.
  • Secretion of inflammatory cytokines (IL-1α, IL-23, MCP-1) was measured via ELISA.

Main Results:

  • Naringenin demonstrated no toxicity at concentrations up to 50 µg/ml.
  • Naringenin significantly inhibited osteoclastogenesis in a dose-dependent manner (up to 96% inhibition).
  • Naringenin markedly reduced the secretion of IL-1α, IL-23, and MCP-1.
  • Naringenin significantly decreased bone resorption markers (up to 86% reduction).

Conclusions:

  • Naringenin effectively inhibits human osteoclastogenesis and osteoclastic bone resorption.
  • Naringenin's anti-resorptive properties suggest its potential as a therapeutic agent.
  • Naringenin may be beneficial in managing bone-related conditions, including periodontitis.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...